Whipplewood Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87K Buy
7
+3
+75% +$812 ﹤0.01% 777
2025
Q4
$1K Buy
+4
New +$1.06K ﹤0.01% 412
2025
Q3
Sell
-13
Closed -$3.41K 786
2025
Q2
$3.41K Sell
13
-44
-77% -$10.7K ﹤0.01% 772
2025
Q1
$3.02K Buy
57
+46
+418% +$11.2K ﹤0.01% 804
2024
Q4
$2.52K Buy
+11
New +$2.52K ﹤0.01% 829

Other funds holding LH

Whipplewood Advisors's LH Position: Q1 2026 in Review

Whipplewood Advisors increased its Labcorp (LH) stake by 75% in Q1 2026, buying an estimated $812 and bringing the position to 7 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #777.

Whipplewood Advisors first reported a position in LH in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.41K in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Whipplewood Advisors held 7 shares of Labcorp worth $1.87K as of Q1 2026.
  • Whipplewood Advisors bought 3 Labcorp shares in Q1 2026, an estimated $812.
  • Labcorp made up ﹤0.01% of Whipplewood Advisors's portfolio in Q1 2026, its #777 holding.
  • Whipplewood Advisors first reported a position in Labcorp in Q4 2024 and has held it in 5 quarters since.
  • Whipplewood Advisors's Labcorp position peaked at $3.41K in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Whipplewood Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.